Search research articles
Contact Us
Filters
Showing results (31-40 of 201) with videos related to
Page
of 21
Sort By:
Nephron. Physiology
|
November 8, 2014
Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms
Yiling Fu, Volker Vallon
Diabetologia
|
August 23, 2018
Development of SGLT1 and SGLT2 inhibitors
Timo Rieg, Volker Vallon
Drugs
|
April 18, 2018
The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
Hadi Fattah, Volker Vallon
Methods in Molecular Medicine
|
July 31, 2003
Tubuloglomerular feedback
Volker Vallon, Jurgen Schnermann
Comprehensive Physiology
|
December 29, 2021
Renal Tubular Handling of Glucose and Fructose in Health and Disease
Volker Vallon, Takahiko Nakagawa
Current Opinion in Nephrology and Hypertension
|
November 18, 2015
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Aleksandra Novikov, Volker Vallon
Comprehensive Physiology
|
June 5, 2013
Pathophysiology of the diabetic kidney
Volker Vallon, Radko Komers
Kidney and Dialysis
|
November 16, 2022
The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
Yuji Oe, Volker Vallon
Nature Reviews. Nephrology
|
August 8, 2017
Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS
Volker Vallon, Scott C Thomson
Current Opinion in Nephrology and Hypertension
|
July 18, 2018
Renal tubular solute transport and oxygen consumption: insights from computational models
Anita T Layton, Volker Vallon
Page
of 21
Search research articles
Search
Showing results (31-40 of 201) with videos related to
Sort By:
Page
of 21
Nephron. Physiology
|
November 8, 2014
Mineralocorticoid-induced sodium appetite and renal salt retention: evidence for common signaling and effector mechanisms
Yiling Fu, Volker Vallon
Diabetologia
|
August 23, 2018
Development of SGLT1 and SGLT2 inhibitors
Timo Rieg, Volker Vallon
Drugs
|
April 18, 2018
The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus
Hadi Fattah, Volker Vallon
Methods in Molecular Medicine
|
July 31, 2003
Tubuloglomerular feedback
Volker Vallon, Jurgen Schnermann
Comprehensive Physiology
|
December 29, 2021
Renal Tubular Handling of Glucose and Fructose in Health and Disease
Volker Vallon, Takahiko Nakagawa
Current Opinion in Nephrology and Hypertension
|
November 18, 2015
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Aleksandra Novikov, Volker Vallon
Comprehensive Physiology
|
June 5, 2013
Pathophysiology of the diabetic kidney
Volker Vallon, Radko Komers
Kidney and Dialysis
|
November 16, 2022
The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1
Yuji Oe, Volker Vallon
Nature Reviews. Nephrology
|
August 8, 2017
Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS
Volker Vallon, Scott C Thomson
Current Opinion in Nephrology and Hypertension
|
July 18, 2018
Renal tubular solute transport and oxygen consumption: insights from computational models
Anita T Layton, Volker Vallon
Page
of 21